If you are an Aetna member and received a letter regarding contract negotiations with NewYork-Presbyterian, you may find out the latest information here.

David Michael Nanus, M.D.

Medical Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

As far back as I remember, I have been interested in improving the care of patients with cancer through research aimed at developing new and more effective therapies, and by providing compassionate care. I am fortunate to work at an institution that enables me to care for patients within an outstanding hospital and medical college, where I am surrounded by like-minded physicians and staff that are most concerned about the well-being of our patients and their family members. The close relationships I develop with my patients and the continued efforts by my colleagues and me to find a cure inspire me to come to work every day with new hope and determination.

Biographical Info

POSITIONS:

  • Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine
  • Director of NewYork-Presbyterian Hospital - Weill Cornell Medicine Healthcare Systems Cancer Program
  • Associate Director for Clinical Services, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine

PROFESSIONAL TRAINING:

Intern, Internal Medicine, University of Wisconsin Hospital & Clinics, Madison, Wisconsin, 1982-83

Resident, Internal Medicine, Albert Einstein College of Medicine, Bronx, New York, 1983-85

Clinical Fellow, Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, 1985-89

Dr. Nanus is an internationally recognized leader in the treatment and care of patients with genitourinary (GU) cancers, including cancers of the prostate, kidney, bladder and testes. He is actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of clinical research trials that incorporate novel targeted therapies for his patients.

Dr. Nanus served as Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine for 14 years prior to becoming the Director of the NewYork-Presbyterian Hospital and Weill Cornell Medicine Healthcare Systems Cancer Program. Dr. Nanus is also the Associate Director of Clinical Services for the Sandra and Edward Meyer Cancer Center. He is the recipient of numerous awards including membership in the American Society for Clinical Investigation and the American Association of Physicians.

Dr. Nanus is a graduate of the University of Illinois and the Chicago Medical School at the Rosalind Franklin University of Medicine and Science. After completing clinical training in Medicine at Albert Einstein and Medical Oncology at Memorial Sloan Kettering Cancer Center, and research training at the Sloan Kettering Institute, he was invited to join the faculty at Memorial Sloan Kettering Cancer Center in 1989. Developing a program in GU cancer, he made several important contributions to clinical and basic research in kidney and prostate cancer. He was recruited to the full-time faculty of Weill Cornell Medical College in 1998.

At Weill Cornell, Dr. Nanus helped develop the Genitourinary (GU) Oncology Research Program focused on understanding the events that contribute to the progression of urologic cancers, and on developing new and more effective therapies to treat advanced prostate, kidney and bladder cancer. As a Director of the Genitourinary Oncology Research Laboratory, he works with a unique interdepartmental team of world class clinical researchers seeking to translate research on the molecular basis of GU cancers into improved cancer treatment.

Honors and Awards

1988   American Society of Clinical Oncology Young Investigators Award for Cancer Research

1988   American Philosophical Society Daland Fellowship for research in clinical medicine

1990   National Kidney Foundation Young Investigator Grant Award

1991   American Cancer Society Career Development Award

1998-2015  Best Doctor, Best Doctors in America

2000   Mid-Career Development Award, National Institutes of Health

2001   Member, American Society for Clinical Investigation (ASCI)

2005   Member, American Association of Physicians (AAP)

2009-15   U.S. News and World Reports Top Doctors (Castle Connolly's estimation among the top 1% in the nation in his or her specialty)

2010-15   Super Doctors (outstanding physicians who have attained a high degree of peer recognition or professional achievement)

2010   2010 Gold DOC Award for sensitivity, kindness and compassion in the practice of medicine, The Arnold P. Gold Foundation

2012-15   Consumer Research Council of America “America’s Top Oncologists”

2014   National Council of American Executives Top Ranked U.S. Executive

2015   Top Doctors for Cancer, Newsweek Magazine 

2016   Top Doctors, New York Magazine 

2016, 2017   Top Doctors New York Metro Area, Castle Connolly 

2016, 2017   America's Top Doctors, Castle Connolly

2016, 2017   America's Top Doctors for Cancer, Castle Connolly 


America's Top Doctors: 14th Edition, 13th Edition, 12th Edition, 11th Edition, 10th Edition 

America's Top Doctors for Cancer: 10th Edition, 9th Edition, 8th Edition, 7th Edition, 6th Edition 

Top Doctors: New York Metro Area: 18th Edition, 17th Edition, 16th Edition, 15th Edition, 14th Edition, 13th Edition, 12th Edition, 11th Edition

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Penile Cancer
Cancer of Urachus
Languages
English
Education 
  • M.D.
    Chicago Medical School, Rosalind Franklin University of Medicine and Science
    1982
Appointments 
  • Mark W. Pasmantier Professor of Hematology and Oncology in Medicine
    Weill Cornell Medical College, Cornell University
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Professor of Urology
    Weill Cornell Medical College, Cornell University
  • Attending Physician
    NewYork-Presbyterian Hospital

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant: 
Memorial Sloan Kettering Cancer Center
Telix Pharmaceuticals
Professional Services: 
Aaronson Rappaport Feinstein & Deutsch, LLP
Amabile & Erman, P.C.
Burns White, LLC
Calderhead, Lockemeyer and Peschke Law Office
Danaher Laganes PC
Hinshaw & Culbertson LLP
Martin, Clearwater & Bell, LLP
McAloon & Friedman, P.C.
Medical College of Wisconsin
O'Brien & Ryan, LLP
Ruprecht Hart Weeks & Ricciardulli, LLP
Shaub, Ahmuty, Citrin & Spratt, LLP
Wadleigh, Starr & Peters, P.L.L.C.
Wicker Smith O'Hara McCoy & Ford, PA
Advisory/Scientific Board Member: 
Dana-Farber Cancer Institute
Janssen Scientific Affairs, LLC
Speaker/Lecturer: 
Aptitude Health